Of 20 host-defense peptides tested, several including lactoferricin and magainin effectively inactivated both herpes simplex virus types 1 and 2, with a simple microplate assay enabling rapid antiviral screening.
Virus-killing peptidesLactoferricin and magainin-related peptides directly inactivated both HSV-1 and HSV-2 — antimicrobial peptides work against viruses too
What the researchers found
Multiple host-defense peptides including lactoferricin and magainin-related peptides directly inactivated HSV-1 and HSV-2 in a validated microplate screening assay, expanding their known antimicrobial spectrum to include antiviral activity.
Why it matters
Herpes infections are lifelong and increasingly drug-resistant. Natural antimicrobial peptides with antiviral activity could provide alternative or complementary treatments to existing antivirals.
How the study worked
In-vitro antiviral screening using MTT microplate assay on Vero cells. 20 host-defense peptides tested for ability to inactivate HSV-1 and HSV-2. Validated against standard plaque reduction assays.
What this study cannot tell us
In-vitro virus inactivation may not translate to in-vivo antiviral efficacy. Peptide concentrations required may exceed achievable tissue levels. Mechanism of viral inactivation not determined.
How to read the evidence
Preliminary in-vitro evidence with validated screening methodology, identifying active peptides against both HSV types.
When this study was published
Published in 2000. Antiviral antimicrobial peptides have been further studied, with some advancing toward clinical development for topical herpes treatment.
The bigger picture
Antimicrobial peptides' spectrum extends to viruses as well as bacteria and fungi. This broadens their therapeutic potential for a wide range of infections.
Questions still open
- Can these peptides reduce herpes transmission when applied topically?
- What is the mechanism of viral inactivation?
- Could these peptides complement existing antiviral drugs?
Common questions
Can natural peptides fight herpes?
How would these be used?
Read the original research
Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 19(3), 187-94
Citation
Yasin, B; Pang, M; Turner, J S; Cho, Y; Dinh, N N; Waring, A J; Lehrer, R I; Wagar, E A. (2000). Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides.. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 19(3), 187-94.